Press Release

February 4, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce full year 2009 earnings on Friday 19 February 2010.

Results press release will be issued at:
12:00 GMT / 07:00 EST

Investor conference call time:
14:00 GMT / 09:00 EST


Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Grégoire, President, Human Genetic Therapies will host the investor and analyst conference call at 14:00 GMT/9:00 EST.

The details of the conference call are as follows:
UK dial in:
0844 800 3850 or 01296 311 600

US dial in:
1 866 8048688 or 1 718 3541175

International dial in:
+44 (0) 1296 311 600

Password/Conf ID:
587 261#

Live Webcast:
http://www.shire.com/shireplc/en/investors


Replay:

A replay of the conference call will be available by phone for two weeks and on our website for 12 months. For further information; please visit our Investor Relations’ website.

For more information:
http://www.shire.com/shireplc/en/investors

Last updated on: 27/08/2010 11:40:18